Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation

Bipolar Disorders
Paul J CarlsonTrisha Suppes

Abstract

Residual depression and medication-induced sedation remain significant problems for many patients with bipolar disorder (BD). Some evidence indicates that bipolar depression may be more responsive to dopaminergic agents, suggesting that adjunctive stimulant medication may be an effective treatment for bipolar depression as well as for medication-induced sedation. However, there are few data regarding the use of these medications in BD, likely due in part to concerns regarding potential stimulant-induced switching and stimulant abuse. In order to evaluate the effectiveness and safety of psychostimulants in BD, we retrospectively reviewed the cases of eight consecutive individuals from our clinic (five with bipolar I and three with bipolar II) who received adjunctive stimulants (either methylphenidate or amphetamine) within the last 2 years. Primary target symptoms of stimulant therapy included residual depression and medication-induced sedation. The degree of clinical change in target symptoms was estimated, and the Clinical Global Impression-BP Version scale (CGI-BP) was used to evaluate the overall severity of illness at baseline, 6 months after stimulant initiation, and at last visit. The eight patients generally showed moder...Continue Reading

References

Jul 1, 1992·Biological Psychiatry·S Kapur, J J Mann
Mar 1, 1992·Journal of the American Academy of Child and Adolescent Psychiatry·G A CarlsonC S Pataki
Apr 1, 1991·Journal of Clinical Psychopharmacology·J FawcettM R Schaff
Aug 1, 1972·Archives of General Psychiatry·S H Snyder
Feb 1, 1983·The American Journal of Psychiatry·E J DrimmerH E Gwirtsman
Oct 1, 1981·The American Journal of Psychiatry·E K SilbermanR M Post
Feb 1, 1980·The British Journal of Psychiatry : the Journal of Mental Science·J BannetR H Belmaker
Nov 1, 1995·The American Journal of Psychiatry·M J GitlinC Hammen
Apr 1, 1995·Journal of the American Academy of Child and Adolescent Psychiatry·T M AchenbachC Stanger
Feb 1, 1995·The American Journal of Psychiatry·S A WestB J McConville
Jun 1, 1996·Journal of the American Academy of Child and Adolescent Psychiatry·J Wozniak, J Biederman
Aug 1, 1996·Journal of the American Academy of Child and Adolescent Psychiatry·J BiedermanE Lelon
Jun 1, 1997·Clinical Neuropharmacology·R B RosseS I Deutsch
Jun 3, 1998·The Journal of Neuropsychiatry and Clinical Neurosciences·J L Schaller, D Behar
Dec 19, 1998·Journal of Affective Disorders·W CoryellM Keller
Mar 16, 2001·Bipolar Disorders·G S SachsS N Ghaemi
Mar 20, 2001·Bipolar Disorders·R S El-Mallakh
Jun 5, 2002·Archives of General Psychiatry·Lewis L JuddMartin B Keller
Oct 5, 2002·The Journal of Clinical Psychiatry·Lori L AltshulerMark A Frye

❮ Previous
Next ❯

Citations

Aug 21, 2012·Current Psychiatry Reports·Susan L McElroy, Paul E Keck
Aug 10, 2011·Journal of American College Health : J of ACH·Simon M W Lejeune
Aug 2, 2008·Clinical Neuropharmacology·Chang-Chih HuangYi-Wei Yeh
Jun 24, 2010·International Clinical Psychopharmacology·Julien MendlewiczUNKNOWN Group for the Study of Resistant Depression (GSRD)
Jul 7, 2014·Attention Deficit and Hyperactivity Disorders·Julia GeisslerTilman Hensch
Feb 28, 2006·Nordic Journal of Psychiatry·Peter Skeppar, Rolf Adolfsson
Sep 15, 2015·Expert Opinion on Pharmacotherapy·Giulio Perugi, Giulia Vannucchi
Jul 10, 2010·Expert Opinion on Drug Safety·Richard Lawrence Merkel
Mar 25, 2014·Pharmacology & Therapeutics·Peter H HutsonAshwin A Patkar
Oct 16, 2010·Biological Psychiatry·Roy H Perlis
Jun 23, 2009·Bipolar Disorders·Joseph F Goldberg, K N Roy Chengappa
Jun 2, 2006·Journal of Affective Disorders·Suhayl NasrKathryn Steiner
Oct 15, 2014·Current Psychiatry Reports·Bernardo Dell'OssoA Carlo Altamura
Oct 25, 2012·Neuroscience and Biobehavioral Reviews·Ulrich Hegerl, Tilman Hensch
Jun 22, 2012·The International Journal of Neuropsychopharmacology·Bernardo Dell'Osso, Terence A Ketter
Feb 2, 2017·Current Psychiatry Reports·Giulio PerugiEttore Favaretto
Jan 1, 2011·Journal of Central Nervous System Disease·Rif S El-MallakhR Jeannie Roberts
Apr 22, 2008·The Cochrane Database of Systematic Reviews·M CandyM King
Sep 16, 2006·Journal of Clinical Psychopharmacology·Eric Lydon, Rif S El-Mallakh
Jan 25, 2006·Molecular Psychiatry·M Gitlin
Nov 12, 2005·Journal of Clinical Psychopharmacology·Hiroyuki UchidaHaruo Kashima
Oct 28, 2005·Harvard Review of Psychiatry·Michael E Thase
Aug 24, 2017·BMC Psychiatry·Martin A KatzmanLarry J Klassen
Nov 8, 2014·Harvard Review of Psychiatry·Heinz Grunze
Aug 3, 2010·CNS Spectrums·Tilman HenschRobert S McIntyre
Jul 12, 2017·Case Reports in Psychiatry·Robert Karoly ChuZainab Samaan
May 25, 2006·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
May 17, 2021·Journal of Neural Transmission·Federico MucciDonatella Marazziti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

© 2021 Meta ULC. All rights reserved